A single arm, open label, phase II, multicenter study to assess the detection of the BRAF V600 mutation on cfDNA from plasma in patients with advanced melanoma P. Rutkowski,P. Pauwels,J. Kerger, B. Jacobs,G. G. Maertens, V. Gadeyne, S. Liebert,B. NeynsAnnals of Oncology（2019）引用 0|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
